Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 11-1999 | 11-1998 | |
| Sales | 1,358 | 781 |
| Cost of Goods | 679 | 521 |
| Gross Profit | 679 | 260 |
| Operating Expenses | 1,901 | 2,930 |
| Operating Income | -1,222 | -2,669 |
| Other Income | 1,222 | 2,669 |
| Net Income Continuous | -1,222 | -2,214 |
| Net Income | $-1,222 | $-2,214 |
| EPS Basic Total Ops | -0.05 | -0.09 |
| EPS Basic Continuous Ops | -0.05 | -0.09 |
| EPS Diluted Total Ops | -0.05 | -0.09 |
| EPS Diluted Continuous Ops | -0.05 | -0.09 |
| EBITDA(a) | $-1,019 | $-2,409 |